Product profile · UK declaration
Royal Canin Fit 32
A dry food positioned for moderately active adult cats with access to the outdoors.
Product and intended use
The UK page describes adult cats aged 1–7 years. Moisture and energy are not provided in the checked analysis panel, so this entry does not estimate a dry-matter or calorie-based ranking.
“Complete” records the manufacturer’s description. It is not an Evidence.pet certification or an independent nutrient analysis.
Declared nutritional analysis
Manufacturer figures, as sold. These are not independent batch-test results. Water content differs between food formats, so the percentages should not be used alone to rank wet, raw and dry foods.
| Component | Declared value |
|---|---|
| Protein | 32% |
| Fat | 15% |
| Fibre | 4.7% |
| Ash | 7.2% |
What is in it?
The UK composition includes poultry and pork proteins, rice, wheat, maize, animal fats, fibre sources, fish oil and psyllium. Poultry is not identified as a single named bird species.
This is a summary. The source and the current pack provide the complete declaration, including additives. Ingredient presence alone does not establish digestibility, nutritional adequacy or clinical benefit.
Claims and evidence
Royal Canin describes a complete food and claims support for weight, hairball management and urinary health. The product is not presented here as a treatment for urinary disease.
No published trial of this exact current formulation has been verified for this entry. This is a limit of our review, not a claim that no research exists.
A Royal Canin-funded weight-loss trial in the library evaluated different diets and strategies. It is not a trial of Fit 32.
Explore ingredients and research
Browse cat studies · Browse ingredients for cats
Related studies provide context. Check the actual animals, diet, dose and outcome before transferring a finding to this food.
Source and review scope
Official UK product information · Royal Canin brand profile
Evidence.pet record PRO-010. Checked 23 September 2026. Next review planned 23 December 2026. No independent batch testing or formal efficacy grade. Formulations may change; check your current pack.